Comorbidités somatiques chez les patients souffrant de schizophrénie traitée. Recommandations actuelles

Nicolas Lefèbvre(Hôpital Civil, Strasbourg), Pierre‐Michel Llorca(Institut Pascal), Andrea Schmitt(Centre National de la Recherche Scientifique), Isabelle Chéreau

Annales Médico-psychologiques revue psychiatrique

December 23, 2005

10.1016/j.amp.2005.11.006

Cited by 15

Related Papers

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)

|European Psychiatry|2018|662

Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial

|BMJ|2022|177

The “Functional Remission of General Schizophrenia” (FROGS) scale: Development and validation of a new questionnaire

|Schizophrenia Research|2009|142

Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020

|Eurosurveillance|2020|129

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France

|EBioMedicine|2020|113